Enter assignee name

EPO Patents = 1

Forward Citations = 2

Loading Chart...

8 inventors (with patents filed for the assignee):

Oren Becker (6 out of 26 patents)

Vered Behar (5 out of 8 patents)

Reut Yosef Hamo (4 out of 4 patents)

4. Eyal Dor-On (3 out of 4 patents)

5. Paul Salama (2 out of 13 patents)

6. Hadas Tamar Pahima (1 out of 1 patent)

7. Chaim Mann Brickman (0 patent)

8. Oren Menahem Becker (0 patent)

6 patents: Sort by Forward Citations

1. 12162868 - Piperazine derivatives, pharmaceutical compositions and methods of use thereof (2024-12-10),

2. 12083111 - Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses (2024-09-10),

3. 11905250 - Methods for preparation of jasmonate compounds (2024-02-20),

4. 11266639 - Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers (2022-03-08),

5. 11096935 - Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses (2021-08-24),

6. 10682346 - Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses (2020-06-16),

Vidac Pharma Ltd. is a clinical-stage biotechnology company focused on discovering and developing innovative drugs for the treatment of cancer and rare genetic diseases. Their lead product candidate, VDA-1102, has shown promising results in preclinical studies and is currently being evaluated in clinical trials. With a commitment to improving patient outcomes and addressing unmet medical needs, Vidac Pharma is dedicated to advancing cutting-edge therapies that have the potential to make a significant impact on the lives of patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

6 Patents

#16 in Ness Ziona

#993 in Israel

Ness Ziona, Israel

Vidac Pharma Ltd.